If a tree falls in the woods and no one is around to sees it, did it happen? And if researchers make discoveries with commercial potential but don’t protect and license their inventions, will they ever reach the market? Unlikely, says University of Iowa Research Foundation (UIRF) Executive Director Marie Kerbeshian, who is also an assistant vice president in the Office of the Vice President for...

A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices. Results of that study were published Aug. 28 online in Nature Digital Medicine, offering the first look at data...

IDx, a privately held AI diagnostics company built on University of Iowa research, announced today that it has filed its De Novo submission to the Food and Drug Administration (FDA) for IDx-DR, an AI-based system for the autonomous detection of diabetic retinopathy — a leading cause of blindness. The FDA has granted IDx-DR with a “Breakthrough Device” designation, which means the submission will...